Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340884 · ClinicalTrials.gov registry record · Phase 2
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
A Phase 2 study, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 92
- Enrollment target
NCT02340884 is a Phase 2 study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 92 participants.
The verdict
NCT02340884, a Phase 2 study, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 92 participants
- Enrollment target
Study Summary
Study Title: A Pilot Randomized Controlled Trial of the Promoting Resilience in Stress Management (PRISM) Intervention for Adolescents and Young Adults with Cancer Study Population and Sample Size: Two cohorts of Adolescent and Young Adult (AYA) patients with diagnosis of new or recurrent cancer between 1 and 10 weeks prior to enrollment: those ages 13-17 (N=50); (2) those ages 18-25 (N=50). Study Design: Pilot randomized controlled trial (RCT). Primary Objective: To test the efficacy of the "Promoting Resilience in Stress Management" (PRISM) among Adolescents and Young Adults with cancer. Primary Outcome: Change in patient-reported resilience (based on score of standardized Connor-Davidson Resilience Scale) at 6 months. Secondary Outcomes: 1. Patient-reported resilience at 2, 4, and 12 months 2. Patient-reported self-efficacy, benefit-finding, psychological distress, quality of life, and health-behaviors at 6 and 12 months. 3. Qualitative assessment of patient-reported goals at 6 and 12 months 4. Development of a cohort of AYA cancer survivors for assessment of long-term psychosocial outcomes Study Duration: 3 years
Interventions
- BEHAVIORAL Promoting Resilience In Stress Management (PRISM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2015-01-30 |
| Est. Completion | 2021-12-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02340884
The ClinicalTrials.gov registry entry for NCT02340884 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Promoting Resilience In Stress Management (PRISM) is the first listed.
NCT02340884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02340884 about?
NCT02340884 is a clinical study titled "A Pilot RCT of the PRISM Intervention for AYAs With Cancer". Study Title: A Pilot Randomized Controlled Trial of the Promoting Resilience in Stress Management (PRISM) Intervention for Adolescents and Young Adults with Cancer Study Population and Sample Size: Two cohorts of Adolescent and Young Adult (AYA) patients with diagnosis of new or recurrent cancer be...
What is the current status of trial NCT02340884?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 92 participants. The study started on 2015-01-30. Estimated completion is 2021-12-19.
What interventions are being tested in trial NCT02340884?
The interventions under investigation include: Promoting Resilience In Stress Management (PRISM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02340884?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.